KMT2A and leukemia: We propose that MLL-oncoprotein dynamics support the activation of a GMP-like program as a secondary relapse mechanism and that ENL likely contributes to the maintenance of this program in MLLr leukemias that are resistant to treatment with menin inhibitors.